Fig. 3From: Therapeutic effect against retinal neovascularization in a mouse model of oxygen-induced retinopathy: bone marrow-derived mesenchymal stem cells versus ConberceptRecruitment of RFP-BMSC to retinal vessel. RFP-BMSC were specifically recruited to the inner surface of retina 3 days after injection. The cell density increased at day 5. Recruited cells integrated into the retinal vasculature and displayed dendritic appearance 10 days after injection. Bar = 200 μmBack to article page